05/23/2025
4:45 PM | Namouni Fouad (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2025
4:45 PM | Patterson Matthew R (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2025
4:45 PM | Beckman Daniella (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2025
4:45 PM | Lubner David Charles (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2025
4:45 PM | Lundberg Sven Ante (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2025
4:45 PM | Kalir Erez (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2025
4:45 PM | Resnick Joshua (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2025
4:47 PM | Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2025
3:05 PM | Vor Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2025
7:35 AM | Vor Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/02/2025
3:30 PM | Choi Han Wook (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for VOR and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Vor Biopharma and its competitors with MarketBeat's FREE daily newsletter. |
03/31/2025
11:15 PM | Vor Biopharma (Filer)
| Form EFFECT | |
03/28/2025
3:33 PM | Vor Biopharma (Filer)
| Form PRE 14A | |
03/20/2025
3:45 PM | Vor Biopharma (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
03/20/2025
3:48 PM | Vor Biopharma (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/20/2025
3:01 PM | Vor Biopharma (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/12/2025
3:29 PM | Attar Eyal C. (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2025
8:34 AM | FMR LLC (Filed by)
Vor Biopharma (Subject)
| Form SCHEDULE 13G/A | |
02/07/2025
3:35 PM | Attar Eyal C. (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2025
3:36 PM | ANG ROBERT (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2025
3:37 PM | Chakraborty Tirtha (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2025
3:01 PM | Vor Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/05/2025
8:19 PM | Choi Han Wook (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
8:20 PM | Attar Eyal C. (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
8:22 PM | Chakraborty Tirtha (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
8:23 PM | ANG ROBERT (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2025
11:15 PM | Vor Biopharma (Filer)
| Form EFFECT | |
01/29/2025
4:24 PM | Vor Biopharma (Filer)
| Form 424B3 | |
01/21/2025
3:24 PM | Vor Biopharma (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
01/08/2025
5:39 PM | Kalir Erez (Reporting)
Vor Biopharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/08/2025
5:41 PM | Kalir Erez (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
8:06 AM | Vor Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/07/2025
3:53 PM | Reprogrammed Interchange LLC (Filed by)
Vor Biopharma (Subject)
| Form SCHEDULE 13D | |
01/02/2025
6:37 PM | Hoffman Reid (Reporting)
Reprogrammed Interchange LLC (Reporting)
Vor Biopharma (Issuer)
Vor Biopharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2025
6:42 PM | Hoffman Reid (Reporting)
Reprogrammed Interchange LLC (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/31/2024
3:15 PM | Attar Eyal C. (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/30/2024
5:51 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by)
Vor Biopharma (Subject)
| Form SCHEDULE 13D/A | |
12/30/2024
5:52 PM | Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2024
3:17 PM | Attar Eyal C. (Reporting)
Vor Biopharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/27/2024
8:05 AM | Vor Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/09/2024
6:39 AM | Vor Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Everyone’s watching Nvidia right now. Here’s why I’m excited. (Ad) So, unless you’ve been living under a rock, you probably saw the news…
Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯
We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer. 🎯 Click here to watch the video and get the free ticker XGPT just flagged. |
11/14/2024
3:33 PM | Paradigm Biocapital Advisors LP (Filed by)
Vor Biopharma (Subject)
| Form SC 13G/A | |
11/08/2024
3:15 PM | ANG ROBERT (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2024
3:15 PM | Attar Eyal C. (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2024
3:15 PM | Quinlan Amy (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2024
3:20 PM | Chakraborty Tirtha (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
3:15 PM | ANG ROBERT (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
3:15 PM | Attar Eyal C. (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
3:15 PM | Chakraborty Tirtha (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
3:15 PM | Quinlan Amy (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2024
3:16 PM | Choi Han Wook (Reporting)
Vor Biopharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/02/2024
3:17 PM | Choi Han Wook (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2024
6:05 AM | Vor Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/05/2024
3:06 PM | Vor Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/30/2024
3:01 PM | Vor Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
3:29 PM | Chakraborty Tirtha (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2024
3:30 PM | ANG ROBERT (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/19/2024
4:04 PM | Jorgensen Nathan D. (Reporting)
Vor Biopharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/26/2024
4:22 PM | Quinlan Amy (Reporting)
Vor Biopharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
Buy VOR Stock Free VOR Stock Alerts